Skip to main content
Midas Edge

908 Devices Inc

For the period ended Sep 30, 2024. Filed Nov 12, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 12, 2024

MASS$9.99-13.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Condensed Consolidated Statements of Stockholders’ Equity

(in thousands, except share amounts)

​​​​​​​​​​​​​​​​​​
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · Accumulated · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · ​ · ​ · Additional · ​ · Other · ​ · ​ · ​ · Total
​ · ​ · Common Stock · ​ · Paid-in · ​ · Comprehensive · ​ · Accumulated · ​ · Stockholders'
​ · Shares · Amount · Capital · ​ · Income · Deficit · Equity
Balances at December 31, 2023​32,519,023​$33​$334,692​$1,365​$(170,599)​$165,491
Issuance of common stock upon exercise of stock options​34,563​​—​​61​​—​​—​​61
Stock-based compensation expense​—​​—​​2,643​​—​​—​​2,643
Vesting of restricted stock units​370,511​​—​​—​​—​​—​​—
Net loss​—​​—​​—​​—​​(10,917)​​(10,917)
Foreign currency translation adjustments​—​​—​​—​​(370)​​—​​(370)
Unrealized loss on marketable securities​—​​—​​—​​(15)​​—​​(15)
Balances at March 31, 2024​32,924,097​$33​$337,396​$980​$(181,516)​$156,893
Issuance of common stock upon exercise of stock options​57,610​​—​​97​​—​​—​​97
Stock-based compensation expense​—​​—​​3,096​​—​​—​​3,096
Issuance of common stock pursuant to the acquisition of RedWave Technology​1,497,171​​2​​8,615​​—​​—​​8,617
Issuance of common stock upon ESPP purchase​67,292​​—​​326​​​​​​​​326
Vesting of restricted stock units​84,713​​—​​—​​—​​—​​—
Net loss​—​​—​​—​​—​​(12,548)​​(12,548)
Foreign currency translation adjustments​—​​—​​—​​(125)​​—​​(125)
Unrealized gains on marketable securities​—​​—​​—​​3​​—​​3
Balances at June 30, 2024​34,630,883​$35​$349,530​$858​$(194,064)​$156,359
Issuance of common stock upon exercise of stock options​41,535​​—​​66​​—​​—​​66
Stock-based compensation expense​—​​—​​3,199​​—​​—​​3,199
Vesting of restricted stock units​40,070​​—​​—​​—​​—​​—
Net loss​—​​—​​—​​—​​(29,295)​​(29,295)
Foreign currency translation adjustments​—​​—​​—​​683​​—​​683
Unrealized gains on marketable securities​—​​—​​—​​27​​—​​27
Balances at September 30, 202434,712,488​$35​$352,795​$1,568​$(223,359)​$131,039
​​​​​​​​​​​​​​​​​​
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · Accumulated · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · ​ · ​ · Additional · ​ · Other · ​ · ​ · ​ · Total
​ · ​ · Common Stock · ​ · Paid-in · ​ · Comprehensive · ​ · Accumulated · ​ · Stockholders'
​ · Shares · Amount · Capital · ​ · Income · Deficit · Equity
Balances at December 31, 2022​31,859,847​$32​$323,969​$798​$(134,200)​$190,599
Issuance of common stock upon exercise of stock options56,547​—​88​—​—​88
Stock-based compensation expense—​—​2,166​—​—​2,166
Vesting of restricted stock units​145,123​​—​​—​​—​​—​​—
Net loss—​—​—​—​(12,532)​(12,532)
Foreign currency translation adjustments​—​​—​​—​​291​​—​​291
Balances at March 31, 2023​32,061,517​$32​$326,223​$1,089​$(146,732)​$180,612
Issuance of common stock upon exercise of stock options​166,226​​—​​301​​—​​—​​301
Stock-based compensation expense​—​​—​​2,578​​—​​—​​2,578
Issuance of common stock upon ESPP purchase​45,082​​—​​259​​—​​—​​259
Vesting of restricted stock units​54,036​​—​​—​​—​​—​​—
Net loss​—​​—​​—​​—​​(9,346)​​(9,346)
Foreign currency translation adjustments​—​​—​​—​​(57)​​—​​(57)
Unrealized gains on marketable securities​—​​—​​—​​112​​—​​112
Balances at June 30, 2023​32,326,861​$32​$329,361​$1,144​$(156,078)​$174,459
Issuance of common stock upon exercise of stock options​15,393​​—​​15​​—​​—​​15
Stock-based compensation expense​—​​—​​2,704​​—​​—​​2,704
Vesting of restricted stock units29,174​​—​​—​​—​​—​​—
Net loss​—​​—​​—​​—​​(7,093)​​(7,093)
Foreign currency translation adjustments​—​​—​​—​​(404)​​—​​(404)
Unrealized gains on marketable securities​—​​—​​—​​248​​—​​248
Balances at September 30, 2023​32,371,428​$32​$332,080​$988​$(163,171)​$169,929
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.